Combined Tumor Infiltrating Lymphocytes and <scp>PD</scp>‐<scp>L1</scp> Status in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
In R/M HNSCC, the combination of PD-L1 CPS and CD8+ TILs is a stronger prognostic biomarker for overall survival compared with either biomarker alone.
Authors
- Collin Brummel (ORCID: https://orcid.org/0000-0001-7198-8560)
- Catherine T. Haring (ORCID: https://orcid.org/0000-0002-9317-6536)
- Sarah M. Dermody (ORCID: https://orcid.org/0000-0003-4928-967X)
- Joshua D. Smith (ORCID: https://orcid.org/0000-0002-2076-7589)
- Jonathan B. McHugh (ORCID: https://orcid.org/0000-0002-6138-8833)
- Paul Swiecicki (ORCID: https://orcid.org/0000-0003-2286-3555)
- Matthew E. Spector (ORCID: https://orcid.org/0000-0001-7646-6075)
- J. Chad Brenner (ORCID: https://orcid.org/0000-0003-3238-1111)
- William Perry (ORCID: https://orcid.org/0000-0003-4122-6578)
Institutions
- University of Michigan (US)
- University of Pittsburgh Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- Head & Neck
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1002/hed.28128
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Michigan
- National Institutes of Health